{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:15:11Z","timestamp":1789827311370,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","award":["RM11715C77336E99"],"award-info":[{"award-number":["RM11715C77336E99"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.119913","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T22:38:04Z","timestamp":1629931084000},"page":"119913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control"],"prefix":"10.1016","volume":"284","author":[{"given":"Flavia Agata","family":"Cimini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Barchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Zuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Pagnotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bertoccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Dule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zampieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Giorgio","family":"Baroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Gisella","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.lfs.2021.119913_bb0005","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00125-019-4909-y","article-title":"Type 2 diabetes: a multifaceted disease","volume":"62","author":"Pearson","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tips.2015.09.003","article-title":"Translational significance of heme oxygenase in obesity and metabolic syndrome","volume":"37","author":"Abraham","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2021.119913_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108073","article-title":"HO-1 overexpression and underexpression: clinical implications","volume":"673","author":"Drummond","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.lfs.2021.119913_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040589","article-title":"Heme Oxygenase-1 signaling and redox homeostasis in physiopathological conditions","volume":"11","author":"Consoli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.lfs.2021.119913_bb0025","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The janus face of the heme oxygenase\/biliverdin reductase system in alzheimer disease: it\u2019s time for reconciliation","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.tips.2008.12.003","article-title":"Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin","volume":"30","author":"Kapitulnik","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2021.119913_bb0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tem.2015.02.001","article-title":"Biliverdin reductase isozymes in metabolism","volume":"26","author":"O\u2019Brien","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.lfs.2021.119913_bb0040","doi-asserted-by":"crossref","first-page":"19916","DOI":"10.1074\/jbc.M314251200","article-title":"Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1","volume":"279","author":"Kravets","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.lfs.2021.119913_bb0045","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1074\/jbc.M108239200","article-title":"Human biliverdin reductase is a leucine zipper-like DNA-binding protein and functions in transcriptional activation of heme oxygenase-1 by oxidative stress","volume":"277","author":"Ahmad","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.lfs.2021.119913_bb0050","doi-asserted-by":"crossref","first-page":"17084","DOI":"10.1074\/jbc.M413121200","article-title":"Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells","volume":"280","author":"Miralem","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.lfs.2021.119913_bb0055","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1073\/pnas.0502173102","article-title":"Human biliverdin reductase: a member of the insulin receptor substrate family with serine\/threonine\/tyrosine kinase activity","volume":"102","author":"Lerner-Marmarosh","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0060","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1096\/fj.13-247015","article-title":"Human biliverdin reductase-based peptides activate and inhibit glucose uptake through direct interaction with the kinase domain of insulin receptor","volume":"28","author":"Gibbs","year":"2014","journal-title":"FASEB J."},{"issue":"8","key":"10.1016\/j.lfs.2021.119913_bb0065","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1096\/fj.201600330RR","article-title":"Interaction of human biliverdin reductase with Akt\/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of akt activation","volume":"30","author":"Miralem","year":"2016","journal-title":"FASEB J."},{"issue":"48","key":"10.1016\/j.lfs.2021.119913_bb0070","doi-asserted-by":"crossref","first-page":"25179","DOI":"10.1074\/jbc.M116.731703","article-title":"Biliverdin reductase a attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3beta phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR) alpha","volume":"291","author":"Hinds","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030387","article-title":"Biliverdin reductase A (BVRA) knockout in adipocytes induces hypertrophy and reduces mitochondria in white fat of obese mice","volume":"10","author":"Stec","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0080","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.bbadis.2019.02.021","article-title":"Reduced biliverdin reductase-a levels are associated with early alterations of insulin signaling in obesity","volume":"1865","author":"Cimini","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"23","key":"10.1016\/j.lfs.2021.119913_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239091","article-title":"Reduced biliverdin reductase-a expression in visceral adipose tissue is associated with adipocyte dysfunction and NAFLD in human obesity","volume":"21","author":"Ceccarelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2021.119913_bb0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2019.02.003","article-title":"Loss of biliverdin reductase-a favors tau hyper-phosphorylation in Alzheimer's disease","volume":"125","author":"Sharma","year":"2019","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.lfs.2021.119913_bb0095","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1007\/s12035-018-1231-5","article-title":"Biliverdin reductase-a mediates the beneficial effects of intranasal insulin in alzheimer disease","volume":"56","author":"Barone","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.lfs.2021.119913_bb0100","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.bbadis.2018.07.005","article-title":"Biliverdin reductase-a impairment links brain insulin resistance with increased abeta production in an animal model of aging: implications for alzheimer disease","volume":"1864","author":"Triani","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.lfs.2021.119913_bb0105","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-a promotes brain insulin resistance in alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.lfs.2021.119913_bb0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.freeradbiomed.2021.01.042","article-title":"Insulin resistance, oxidative stress and mitochondrial defects in Ts65dn mice brain: a harmful synergistic path in down syndrome","volume":"165","author":"Lanzillotta","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JAD-2012-121045","article-title":"HO-1\/BVR-a system analysis in plasma from probable Alzheimer\u2019s disease and mild cognitive impairment subjects: a potential biochemical marker for the prediction of the disease","volume":"32","author":"Di Domenico","year":"2012","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0120","doi-asserted-by":"crossref","first-page":"p. le3","DOI":"10.1074\/jbc.L110.133520","article-title":"Curcumin and alzheimer disease: this marriage is not to be performed","volume":"286","author":"Mancuso","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119913_bb0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000441419","article-title":"Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of Down\u2019s syndrome","volume":"16","author":"Tramutola","year":"2016","journal-title":"Neurodegener. Dis."},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.lfs.2021.119913_bb0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2362.2007.01786.x","article-title":"Glucose transporter expression on the plasma membrane of resting and activated white blood cells","volume":"37","author":"Maratou","year":"2007","journal-title":"Eur. J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/cyto.a.20108","article-title":"Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry","volume":"64","author":"Dimitriadis","year":"2005","journal-title":"Cytometry A"},{"issue":"5","key":"10.1016\/j.lfs.2021.119913_bb0145","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1530\/EJE-08-0797","article-title":"Studies of insulin resistance in patients with clinical and subclinical hypothyroidism","volume":"160","author":"Maratou","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0150","first-page":"182","article-title":"Investigations of cellular glucose transport and its regulation under the influence of insulin in human peripheral blood lymphocytes","volume":"61","author":"Piatkiewicz","year":"2010","journal-title":"Endokrynol. Pol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0155","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00005-009-0052-7","article-title":"Cellular glucose transport and glucotransporter 4 expression as a therapeutic target: clinical and experimental studies","volume":"57","author":"Czech","year":"2009","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"issue":"11","key":"10.1016\/j.lfs.2021.119913_bb0160","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1007\/s00125-008-1132-7","article-title":"Downregulation of genes involved in NFkappaB activation in peripheral blood mononuclear cells after weight loss is associated with the improvement of insulin sensitivity in individuals with the metabolic syndrome: the GENOBIN study","volume":"51","author":"de Mello","year":"2008","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0165","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.metabol.2007.08.024","article-title":"Effect of weight loss on cytokine messenger RNA expression in peripheral blood mononuclear cells of obese subjects with the metabolic syndrome","volume":"57","author":"de Mello","year":"2008","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.lfs.2021.119913_bb0170","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/01.CIR.0000142055.53122.FA","article-title":"Circulating mononuclear cells in the obese are in a proinflammatory state","volume":"110","author":"Ghanim","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0175","first-page":"F323","article-title":"Loss of biliverdin reductase-a promotes lipid accumulation and lipotoxicity in mouse proximal tubule cells","volume":"315","author":"Adeosun","year":"2018","journal-title":"Am. J. Phys. Renal Phys."},{"issue":"12 Pt A","key":"10.1016\/j.lfs.2021.119913_bb0180","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.bbadis.2014.10.004","article-title":"Inactivation of brain Cofilin-1 by age, Alzheimer's disease and gamma-secretase","volume":"1842","author":"Barone","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.lfs.2021.119913_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2019.108072","article-title":"CRISPR Cas9-mediated deletion of biliverdin reductase a (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation","volume":"672","author":"Gordon","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.lfs.2021.119913_bb0190","doi-asserted-by":"crossref","first-page":"4712053","DOI":"10.1155\/2016\/4712053","article-title":"Nanoparticle delivered human biliverdin reductase-based peptide increases glucose uptake by activating IRK\/Akt\/GSK3 Axis: the peptide is effective in the cell and wild-type and diabetic Ob\/Ob mice","volume":"2016","author":"Gibbs","year":"2016","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3358","article-title":"Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease","volume":"37","author":"Cimini","year":"2021","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.lfs.2021.119913_bb0200","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.diabres.2019.04.033","article-title":"Association between serum total bilirubin levels and the risk of type 2 diabetes mellitus","volume":"152","author":"Yang","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.lfs.2021.119913_bb0205","doi-asserted-by":"crossref","first-page":"5681296","DOI":"10.1155\/2020\/5681296","article-title":"Relationship between serum indirect bilirubin level and insulin sensitivity: results from two independent cohorts of obese patients with impaired glucose regulation and type 2 diabetes mellitus in China","volume":"2020","author":"Zhang","year":"2020","journal-title":"Int. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0210","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"29","key":"10.1016\/j.lfs.2021.119913_bb0215","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor alpha","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.lfs.2021.119913_bb0220","article-title":"Rats genetically selected for high aerobic exercise capacity have elevated plasma bilirubin by upregulation of hepatic biliverdin reductase-a (BVRA) and suppression of UGT1A1","volume":"9","author":"Hinds","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0225","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00000441-200512000-00004","article-title":"Epidemiology of the metabolic syndrome","volume":"330","author":"Reynolds","year":"2005","journal-title":"Am J Med Sci"},{"issue":"18","key":"10.1016\/j.lfs.2021.119913_bb0230","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0235","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jcb.26174","article-title":"Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus","volume":"119","author":"Akash","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.lfs.2021.119913_bb0240","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1096\/fj.09-144592","article-title":"Characterization of the human biliverdin reductase gene structure and regulatory elements: promoter activity is enhanced by hypoxia and suppressed by TNF-alpha-activated NF-kappaB","volume":"24","author":"Gibbs","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0245","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12974-018-1155-z","article-title":"Biliverdin reductase-a attenuated GMH-induced inflammatory response in the spleen by inhibiting toll-like receptor-4 through eNOS\/NO pathway","volume":"15","author":"Zhang","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.lfs.2021.119913_bb0250","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2012.00047","article-title":"Go green: the anti-inflammatory effects of biliverdin reductase","volume":"3","author":"Wegiel","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0255","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molimm.2014.09.003","article-title":"Tat-biliverdin reductase a inhibits inflammatory response by regulation of MAPK and NF-kappaB pathways in raw 264.7 cells and edema mouse model","volume":"63","author":"Kim","year":"2015","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.lfs.2021.119913_bb0260","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00011-018-1151-x","article-title":"A review on heme oxygenase-1 induction: is it a necessary evil","volume":"67","author":"Waza","year":"2018","journal-title":"Inflamm. Res."},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0265","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1161\/HYPERTENSIONAHA.108.124701","article-title":"Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats","volume":"53","author":"Nicolai","year":"2009","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0270","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1210\/en.2008-1370","article-title":"Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in goto-kakizaki rats","volume":"150","author":"Ndisang","year":"2009","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0275","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.110.151423","article-title":"Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice","volume":"56","author":"Burgess","year":"2010","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.lfs.2021.119913_bb0280","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/ars.2011.4360","article-title":"Potential therapeutic effects of natural heme oxygenase-1 inducers in cardiovascular diseases","volume":"18","author":"Barbagallo","year":"2013","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.lfs.2021.119913_bb0285","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbrc.2013.02.037","article-title":"Heme oxygenase-2\/adiponectin protein-protein interaction in metabolic syndrome","volume":"432","author":"Vanella","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2021.119913_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079270","article-title":"The heme oxygenase system rescues hepatic deterioration in the condition of obesity co-morbid with type-2 diabetes","volume":"8","author":"Salley","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cell.2014.04.043","article-title":"Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man","volume":"158","author":"Jais","year":"2014","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0300","first-page":"R207","article-title":"Heme oxygenase, a novel target for the treatment of hypertension and obesity?","volume":"302","author":"Hosick","year":"2012","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"2","key":"10.1016\/j.lfs.2021.119913_bb0305","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/ijo.2011.78","article-title":"Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice","volume":"36","author":"Csongradi","year":"2012","journal-title":"Int. J. Obes."},{"issue":"5","key":"10.1016\/j.lfs.2021.119913_bb0310","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/oby.2011.365","article-title":"High-fat diet exacerbates renal dysfunction in SHR: reversal by induction of HO-1-adiponectin axis","volume":"20","author":"Cao","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0315","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1124\/jpet.106.107482","article-title":"Up-regulation of heme oxygenase provides vascular protection in an animal model of diabetes through its antioxidant and antiapoptotic effects","volume":"319","author":"Kruger","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.lfs.2021.119913_bb0320","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/359732","article-title":"Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity","volume":"2010","author":"Ndisang","year":"2010","journal-title":"Mediat. Inflamm."},{"issue":"7","key":"10.1016\/j.lfs.2021.119913_bb0325","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1194\/jlr.M800610-JLR200","article-title":"The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice","volume":"50","author":"Peterson","year":"2009","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.lfs.2021.119913_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087936","article-title":"The heme oxygenase system suppresses perirenal visceral adiposity, abates renal inflammation and ameliorates diabetic nephropathy in zucker diabetic fatty rats","volume":"9","author":"Ndisang","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0335","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/jpet.107.135285","article-title":"Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in zucker rats and reduce adipogenesis in human mesenchymal stem cells","volume":"325","author":"Kim","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2021.119913_bb0340","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11010-007-9643-y","article-title":"The protective role of carotenoids against 7-keto-cholesterol formation in solution","volume":"309","author":"Palozza","year":"2008","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.lfs.2021.119913_bb0345","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/oby.20559","article-title":"Increased HO-1 levels ameliorate fatty liver development through a reduction of heme and recruitment of FGF21","volume":"22","author":"Hinds","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"10.1016\/j.lfs.2021.119913_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012371","article-title":"Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus","volume":"5","author":"Bao","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.lfs.2021.119913_bb0355","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12192-018-0903-4","article-title":"Correlation between heat shock proteins, adiponectin, and T lymphocyte cytokine expression in type 2 diabetics","volume":"23","author":"Mahmoud","year":"2018","journal-title":"Cell Stress Chaperones"},{"issue":"9","key":"10.1016\/j.lfs.2021.119913_bb0360","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.2337\/diabetes.52.9.2338","article-title":"Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism","volume":"52","author":"Bruce","year":"2003","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.lfs.2021.119913_bb0365","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1464-5491.2006.01879.x","article-title":"Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with type 2 diabetes and microangiopathy","volume":"23","author":"Adaikalakoteswari","year":"2006","journal-title":"Diabet. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:08:02Z","timestamp":1762211282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521009000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":73,"alternative-id":["S0024320521009000"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119913","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119913"}}